Description

3-Isoquinolinecarboxamide, n-[(1S)-4-[(Aminoiminomethyl)Amino]-1-[[[[4-(Trifluoromethyl)Phenyl]Methyl]Amino]Carbonyl]Butyl]- is a high-purity, non-peptidic small molecule compound of significant interest in advanced pharmaceutical research and development. This compound is valued for its potential as a key intermediate or active pharmaceutical ingredient (API) in the synthesis of novel therapeutic agents. It is primarily sought by pharmaceutical R&D laboratories and contract manufacturing organizations (CMOs) working on targeted drug discovery programs.

Application

• Pharmaceutical Intermediate: Serves as a critical building block in the synthesis of potential drug candidates targeting specific biological pathways.
• Protease Inhibitor Research: Used in the development and screening of novel protease inhibitors due to its structural motifs.
• Chemical Biology Probes: Acts as a tool compound for studying enzyme function and protein-ligand interactions in biochemical assays.
• Preclinical Drug Development: Employed in the early-stage development of new chemical entities (NCEs) for various therapeutic areas.
• Reference Standard: Supplied as a high-purity analytical standard for method development and quality control in API manufacturing.
• Custom Synthesis: Used as a starting material for the custom synthesis of more complex, proprietary molecules for client-specific research projects.

Basic Information

Product Name	3-Isoquinolinecarboxamide, n-[(1S)-4-[(Aminoiminomethyl)Amino]-1-[[[[4-(Trifluoromethyl)Phenyl]Methyl]Amino]Carbonyl]Butyl]-
CAS No.	929611-17-6
Molecular Formula	C23H25F3N6O2
Molecular Weight	474.48 g/mol
Synonyms	N-[(1S)-4-(Carbamimidamido)-1-({[4-(trifluoromethyl)benzyl]carbamoyl})butyl]isoquinoline-3-carboxamide; (S)-N-(4-Guanidino-1-((4-(trifluoromethyl)benzyl)amino)-1-oxobutan-2-yl)isoquinoline-3-carboxamide; 929611-17-6; UNII-9V2I2F2X7P; 9V2I2F2X7P; AGN-PC-0E7Q1P; BDBM50382617; ZINC000003869777; SCHEMBL12445077.
EINECS	Contact for details

Quality Control

Our 3-Isoquinolinecarboxamide derivative is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity and spectroscopic identification (NMR, MS), to ensure it meets the stringent requirements of pharmaceutical research. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting identity, purity, and impurity profiles.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and should be handled in a dry environment to prevent degradation. For long-term storage, consider desiccated conditions.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.